Newsletter Subject

Earn a 630% Gain in Defiance of Climate Alarmists

From

energyandcapital.com

Email Address

newsletter@energyandcapital.com

Sent On

Thu, Nov 4, 2021 07:09 PM

Email Preheader Text

If we truly want to transition to a cleaner, more environmentally sustainable energy and transportat

If we truly want to transition to a cleaner, more environmentally sustainable energy and transportation economy, we should not rely on bureaucratic dog and pony shows. Instead, we should rely on the one thing that never lets us down: free market capitalism. If we truly want to transition to a cleaner, more environmentally sustainable energy and transportation economy, we should not rely on bureaucratic dog and pony shows. Instead, we should rely on the one thing that never lets us down: free market capitalism. [Energy and Capital logo] Earn a 630% Gain in Defiance of Climate Alarmists [Jeff Siegel Photo] By [Jeff Siegel]( Written Nov 04, 2021 As an unapologetic environmentalist, I’ve long been an advocate of transitioning to a cleaner, more sustainable energy and transportation economy. But as an unapologetic libertarian, I’ve also long been an advocate of seeking market-based solutions to make this transition possible instead of relying on imbecilic government intervention. Now, this week, world leaders have gathered in Glasgow to discuss how countries from all across the globe could work together to cut greenhouse gas emissions. But instead of embracing the only proven agent of change — free markets — they continued to rely on unreasonable mandates and general bureaucratic buffoonery, which, as history shows, always leads to failure. You know the old proverb: You can attract more flies with honey than with vinegar. And government intervention and directives represent the bitterest of vinegars. My point is simple: If we truly want to transition to a cleaner, more environmentally sustainable energy and transportation economy, we should not rely on bureaucratic dog and pony shows. Instead, we should rely on the one thing that never lets us down: free market capitalism. Nowhere is this more obvious than in Brazil, where private investors are now funding solar projects at a record pace through a mechanism that allows them to earn monthly distributions on their initial investments. And it ain’t chump change. The Options Trading "Training Video" Retirees Can’t Get Enough Of Options expert Jeff Clark is on a mission to show every American at or near retirement how easy it is to trade options. His 3-Stock Retirement Blueprint shows you how to trade better than ever before. [Click here to learn the names and tickers of these 3 stocks.]( One project is currently showing that for every $1,000 invested, you earn an estimated $7,306 in dividends. That’s a gain in excess of 630%. Check it out… [brazilsol] And here’s the best thing about this opportunity… It’s not tied to the stock market. So even if the broader markets are tanking, your returns are not affected. It doesn’t move with the market. It just provides steady income. You don’t need a broker (or to pay broker fees) to invest either, and there’s no cap on your investment. You could even do monthly investments of $1,000, and your estimated dividends would come to $728,841. Double up to $2,000, and you’re looking at estimated dividends exceeding $1.4 million. While world governments are tripping over themselves trying to figure out how to force people to transition to a cleaner energy economy, smart investors are using the power of the free market to not only enable this transition but make a ton of cash in the process. [Dr. Fauci Backs New COVID Technology (20-cent stock to soar)]( Incredibly enough, Dr. Anthony Fauci is backing a new COVID-fighting technology. He says it merits “serious consideration” and even uses it himself. It’s not a vaccine, but that hasn’t stopped other experts from getting behind it... The Centers for Disease Control (CDC) just greenlighted this device for reopening schools and businesses. And the FDA is on board too, lifting regulatory restrictions to deploy this everywhere. One tiny tech stock owns all of the patents on this technology. For a brief window, you can buy it for $0.20 per share. [Click here for the full story.]( I know it’s not popular to say these days, but no matter how you slice it, there’s no better system for initiating change than free markets... especially when you consider that you can be on the receiving end of huge profits that only free market capitalism can offer. Now, this particular project in Brazil is being run by a U.S. company that essentially connects you to various solar projects all over the world and acts as the middleman, providing project developers with the capital they need and investors like you with your monthly dividends. To get a piece of this action — an investment that could deliver an estimated 630% gain without the risk that comes with investing in a stock — [check out m]([y full report](, which includes access to the contact information you’ll need to profit from this new Brazil solar project. And don’t worry if $1,000 is too much for you to invest at one time. You can actually invest as little as $100 in this deal and still earn the same estimated 630% gains. Look, I’m not saying you should avoid the stock market. In fact, that’s how I make most of my money. But an investment like this — an investment that’s virtually guaranteed to deliver gains in excess of 630% and can never be derailed by broader market sell-offs — is just a no-brainer. [Get in on this action for yourself.]( To a new way of life and a new generation of wealth... [Jeff Siegel Signature] Jeff Siegel [[follow basic]@JeffSiegel on Twitter]( --------------------------------------------------------------- Have You Heard of Delta Plus? COVID-19 has a new variant, and people are calling it “delta plus.” However, researchers are not worried about this new variant because the vaccine will help us fight it off. This is why the $1 trillion biotech industry is so hot right now. More and more drugs are going through the pipeline — and quickly. And this pandemic only gave us a tiny glimpse into the biotech industry’s "100-year flood." Harvard estimates there’s $125 billion worth of discoveries currently waiting their turn in the FDA pipeline. And now that we have a handle on COVID, the FDA is ready to throw the kitchen sink at more game-changing drugs. I have a “Flood List” of small biotech stocks that could deliver Earth-shattering gains in the weeks ahead. And smart investors who get in now could make a fortune on an unprecedented surge of essential treatments pouring out of the FDA pipeline. [Access the list here…]( Browse Our Archives [Shipping Rates up Big]( [Once Bitcoin Is Cracked, It’s Worthless]( [Options Action Alert: “Be Fearful When Others Are Greedy”]( [Options Action Alert — This Chipkmaker Is Firing on All Circuits]( [Trump’s SPAC Deal With Digital World Acquisition Corp. (NASDAQ: DWAC) Will Be a Giant Failure]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2021, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.](

Marketing emails from energyandcapital.com

View More
Sent On

08/12/2024

Sent On

06/12/2024

Sent On

06/12/2024

Sent On

04/12/2024

Sent On

04/12/2024

Sent On

02/12/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.